Authors


Ryan Caldeiro, MD

Latest:

An Integrated Care Approach to Identifying and Treating the Suicidal Person in Primary Care

Although psychiatrists may be better trained to treat suicidal patients, most patients with suicidal ideation are receiving care outside of specialty psychiatric settings and can benefit from interventions in primary care.


David W. Covington, LPC, MBA

Latest:

Mini Quiz: A New Dawn in Suicide Prevention

Psychiatric leadership is essential to the success of efforts toward mitigating suicide risk. That said, can suicide be prevented? Take the quiz and learn more.


Michael F. Hogan, PhD

Latest:

Zero Suicide: The Dogged Pursuit of Perfection in Health Care

More than a slogan, the zero suicide approach applies evidence about what works in the detection, treatment, and management of individuals with intense suicidality.


Nicole T. M. Hill, MBMSc

Latest:

Safe Communication About Suicide in the Digital Age

The incidence of suicidal ideation and self-harm behavior increases rapidly during adolescence and represents a period of heightened suicide risk.


Jo Robinson, PhD

Latest:

Safe Communication About Suicide in the Digital Age

The incidence of suicidal ideation and self-harm behavior increases rapidly during adolescence and represents a period of heightened suicide risk.


Simon Rice, PhD

Latest:

Mini Quiz: Peer-to-Peer Communication Guidelines About Suicide

Suicide is a leading cause of global mortality in those aged 25 years or younger. How can we promote safe communication about suicide in the digital age?


John Read, PhD

Latest:

Raising Doubts About ECT

ECT has been in use for decades, but does that mean it is safe or effective?


James Davies, PhD

Latest:

The International Antidepressant Withdrawal Crisis: Time to Act

This Letter to the Editor is in response to the article published in Psychiatric Times, “Sorting Out the Antidepressant ‘Withdrawal’ Controversy,” by Ronald W. Pies, MD and David N. Osser, MD.


Sarra Nazem, PhD

Latest:

Suicide Risk Assessment and Management: Tips for Improving Care and Outcomes

Determining how to ensure delivery of excellent care while balancing medicolegal demands may seem to be an impossible task. When done in a collaborative way, safety planning can help the clinician better understand risk and targets for intervention.


Christina Salama

Latest:

An Update on Pica: Prevalence, Contributing Causes, and Treatment

In this overview of pica, we review its causes and prevalence. In addition, we discuss some of the associated complications as well as current treatment strategies.


Elizabeth A. Varas, MD

Latest:

The Lessons of COVID-19 as We Face the Challenge of Climate

How can we mitigate climate issues without harming working Americans?


Jose M. Rubio, MD

Latest:

Key Concepts About Polypharmacy in Psychotic Disorders

Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.


Elizabeth Haase, MD

Latest:

Exploring the Connections Between Mental Health and Our Environment

The articles in this Psychiatric Times Special Report highlight the relationship of health to the environment.


Omar Reda, MD

Latest:

The Power of Caring Adulthood Experiences

Caring adulthood experiences have the power to combat some of the impacts of adverse childhood experiences.


Traolach S. Brugha, MD

Latest:

Autism in Adulthood: Widespread, Invisible, Neglected, Misunderstood-Not Our Problem?

Autism was first described by child specialists, and even today most autism-specific services are focused only on children. This CME provides a comprehensive overview of autism in adults.



Jon Betwee, MD

Latest:

A Malpractice Marathon

A courageous piece that tells the story about a lawsuit that dragged on for nearly two decades after the sudden and unexpected death of this psychiatrist's patient.


Larry O. Sanders, MD

Latest:

Cariprazine May Decrease Substance Abuse in Patients With Bipolar I Disorder

Substance use disorders are a common comorbidity in individuals with bipolar disorder. Adding cariprazine to their medication regimen may improve symptoms of both disorders.


Lynnette A. Averill, PhD

Latest:

Ketamine for Stress-Related Psychopathology and Suicidality: A Brief Update

This CME provides a comprehensive understanding of psychopharmacologic treatments for stress-induced psychopathology and the need for novel, rapid-acting agents.


Christopher L. Averill

Latest:

Ketamine for Stress-Related Psychopathology and Suicidality: A Brief Update

This CME provides a comprehensive understanding of psychopharmacologic treatments for stress-induced psychopathology and the need for novel, rapid-acting agents.


Chadi G. Abdallah, MD

Latest:

Ketamine for Stress-Related Psychopathology and Suicidality: A Brief Update

This CME provides a comprehensive understanding of psychopharmacologic treatments for stress-induced psychopathology and the need for novel, rapid-acting agents.


Michael F. Myers, MD

Latest:

Becoming a Doctors’ Doctor

A teaching moment never to be forgotten, little did the author know that this action on his patient's part would be the harbinger of an amazing career looking after physicians.


Andrew Campbell-Watt

Latest:

The Complexities Behind the Act of Suicide

A layperson's perspective after deliberating on the meaning of suicide for decades after the loss of his wife.


Tarek K. Rajji, MD

Latest:

COVID-19, Cognition, and Dementias: What Role Has the Pandemic Played?

How does COVID-19 contribute to cognitive impairment in older adults and future cases of dementia?


Waqas Ullah Khan, MD

Latest:

Schizophrenia in Later Life: Patient Characteristics and Treatment Strategies

With the prevalence of schizophrenia in older adults set to double and reach 1.1 million people in the US by 2025, greater attention to research and policy regarding this population is needed.


Sophia Vinogradov, MD

Latest:

Common Neural Abnormalities in Psychotic Disorders

Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.




Jane Gould, PhD

Latest:

Left to Our Own Devices: Outsmarting Smart Technology to Reclaim Our Relationships, Health, and Focus

As interest in mental health technology grows, so do questions about its risks and benefits. more in this book review.


David L. Nathan, MD

Latest:

21st Century Reefer Madness

Many have said that truth is the first casualty of war. In the war on drugs, truth died before the first shot was fired.

© 2024 MJH Life Sciences

All rights reserved.